Genómica, a company of the Zeltia Group (ZEL.MC) leader in molecular diagnostic products, is developing an updated version of its product CLART? PneumoVir for the specific and urgent detection of the New A/H1N1 Influenza. For the development of this test, Genómica is collaborating with various Spanish and international hospitals. Over the past two months a great number of suspicious samples have been analyzed.
Read More…
Related Posts
- Swine Flu: NIAID Set To Launch Clinical Trials To Test 2009 H1N1 Influenza Vaccine Candidates
- LyfeTec, Inc. Announces Its Influenza A/B Test Kit Tests Help Detect Possibility In Swine Flu Infected Patients
- Diagnostic Hybrids Receives FDA Emergency Use Authorization For D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
- Swine Flu Update, Thursday, 18th February, 2010, Ireland
- Swine Flu Pandemic Weekly Report Thursday 11 February 2010, Wales
- Swine Flu In Pregnancy – What To Look Out For
- Voluntary System Works For Swine Flu Vaccination
- Swine Flu Update, Thursday, 4th February, 2010, Ireland
- Swine Flu Vaccination Available For All Until March 31, Ireland
- Swine Flu Update, Thursday, 28th January, 2010, Ireland
- H1N1 Flu (Swine Flu) Still Spreading In Some Parts Of The World, But Cases Generally Falling, World Health Organization
- Symptoms of H1N1 (Swine Flu)
- Swine Flu Pandemic Weekly Report Thursday 21 January 2010, Wales
- Welsh Assembly Government Encourages Parents To Have Children Under Five Vaccinated Against Swine Flu, Wales
- VaxInnate Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine To Biological E.; Vaccine Could Become Available For Use In India This Year
Tags: designing, diagnostic, efficacy, genomica, quick, swine, test
This entry was posted
on Wednesday, June 24th, 2009 at 1:06 am and is filed under Uncategorized.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.
